AbstractObjectivesSeniors are particularly vulnerable to complications resulting from influenza infection. Numerous influenza vaccines are available to immunize US seniors, and practitioners must decide which product to use. Options include trivalent and quadrivalent standard-dose inactivated influenza vaccines (IIV3 and IIV4 respectively), as well as a high-dose IIV3 (HD). Our research examines the public health impact, budget impact, and cost-utility of HD versus IIV3 and IIV4 for immunization of US seniors 65 years of age and older.MethodsOur model was based on US influenza-related health outcome data. Health care costs and vaccine prices were obtained from the Centers for Medicare and Medicaid Services. Efficacies of IIV3 and IIV4 were ...
ObjectivesDespite a high vaccine uptake rate of over 80% in South Korea, the disease burden of influ...
<p><b>Background</b>: Influenza is responsible for a significant disease burden annually, especially...
Influenza is a contagious respiratory disease that causes severe illness and death, particularly in ...
AbstractObjectivesSeniors are particularly vulnerable to complications resulting from influenza infe...
The burden of influenza is disproportionally higher among older adults. We evaluated the relative va...
Seasonal influenza infects approximately 10-20% of Canadians each year, causing an estimated 12,200 ...
ABSTRACTBackground Clinical evidence supports use of enhanced influenza vaccines in older adults. Fe...
ABSTRACTThe highdose quadrivalent influenza vaccine (QIVHD) has shown improved protection against in...
The influenza-related disease burden is highest among the elderly. We evaluated the relative vaccine...
Objective: To estimate the potential cost-effectiveness of quadrivalent influenza vaccine compared w...
Objective: To compare the economic impact of high-dose trivalent (HD) versus standard-dose trivalent...
Adults 65 years and older (hereinafter referred to as seniors) are at greater risk for complications...
To estimate the potential cost-effectiveness of quadrivalent influenza vaccine compared with trivale...
Abstract Influenza immunization protects seniors against influenza and its potentially serious compl...
Background: Adults 65 years and older (seniors) experience more complications following influenza in...
ObjectivesDespite a high vaccine uptake rate of over 80% in South Korea, the disease burden of influ...
<p><b>Background</b>: Influenza is responsible for a significant disease burden annually, especially...
Influenza is a contagious respiratory disease that causes severe illness and death, particularly in ...
AbstractObjectivesSeniors are particularly vulnerable to complications resulting from influenza infe...
The burden of influenza is disproportionally higher among older adults. We evaluated the relative va...
Seasonal influenza infects approximately 10-20% of Canadians each year, causing an estimated 12,200 ...
ABSTRACTBackground Clinical evidence supports use of enhanced influenza vaccines in older adults. Fe...
ABSTRACTThe highdose quadrivalent influenza vaccine (QIVHD) has shown improved protection against in...
The influenza-related disease burden is highest among the elderly. We evaluated the relative vaccine...
Objective: To estimate the potential cost-effectiveness of quadrivalent influenza vaccine compared w...
Objective: To compare the economic impact of high-dose trivalent (HD) versus standard-dose trivalent...
Adults 65 years and older (hereinafter referred to as seniors) are at greater risk for complications...
To estimate the potential cost-effectiveness of quadrivalent influenza vaccine compared with trivale...
Abstract Influenza immunization protects seniors against influenza and its potentially serious compl...
Background: Adults 65 years and older (seniors) experience more complications following influenza in...
ObjectivesDespite a high vaccine uptake rate of over 80% in South Korea, the disease burden of influ...
<p><b>Background</b>: Influenza is responsible for a significant disease burden annually, especially...
Influenza is a contagious respiratory disease that causes severe illness and death, particularly in ...